Bird flu, Avian influenza, Diabetes, Cholesterol, Caner, HIV

Medical News Today - Breast Cancer News (5 unread)

OncoMune Publishes Positive Results Of OCM-8054 - Breast Cancer Dependency On BORIS Unequivocally Demonstrated By RNA Interference

Posted: September 5th, 2008, 12:00pm EDT

OncoMune LLC, a biotechnology company focused on developing targeted cancer therapeutics, announced the publication of its preclinical OCM-8054 data. The publication entitled, "Selective apoptosis of breast cancer cells by siRNA targeting of BORIS," appeared in the May 23rd 2008 issue of the scientific journal, Biochemical and Biophysical Research Communications, Volume 370, Issue 1, Pages 109-112.
Black Women Less Likely Than White Women To Receive Follow-Up Treatments After Breast Cancer Surgery, Study Finds

Posted: September 5th, 2008, 11:00am EDT

Black women who undergo a lumpectomy surgery to treat early-stage breast cancer are less likely than their white counterparts to receive the recommended follow-up radiation therapy treatments, according to study released on Wednesday, Reuters/Boston Globe reports.
Agendia Launches TargetPrint(R) For Breast Cancer Patients

Posted: September 5th, 2008, 7:00am EDT

Agendia, a world leader in molecular cancer diagnostics, announced the launch of TargetPrint(R), a new diagnostic test that allows physicians to quantitatively determine the gene expression levels of the estrogen receptor (ER), progesterone receptor (PR) and Human Epidermal growth factor Receptor 2 (HER2) in breast cancer tumor biopsies.
Blacks Less Likely Than Whites To Receive Standard Of Care In Radiation Therapy For Breast Cancer

Posted: September 5th, 2008, 7:00am EDT

Black women are less likely than white women to receive radiation therapy after a lumpectomy, the standard of care for early stage breast cancer, according to a new study by researchers at The University of Texas M. D. Anderson Cancer Center. The study, the largest of its kind, was presented in advance of the American Society of Clinical Oncology (ASCO) Breast Cancer Symposium, and is the first national study to examine such racial disparities in radiation therapy.
Change In HER2 Status After Treatment With Herceptin Discovered By M. D. Anderson Study

Posted: September 5th, 2008, 7:00am EDT

Researchers at The University of Texas M. D. Anderson Cancer Center have discovered that when treated with Herceptin prior to surgery, 50 percent of HER2 positive, breast cancer patients showed no signs of disease at the time of surgery. However, of those women who had residual disease, about one-third had tumors that converted from HER2 positive to HER 2 negative status -possibly indicating a resistance to the targeted therapy.

← September 4 (2 items) September 7 (1 item) →

My Health News » Medical News Today - Breast Cancer News » September 5, 2008

Feeds

Medical News Today - Breast Cancer News (5 unread)

OncoMune Publishes Positive Results Of OCM-8054 - Breast Cancer Dependency On BORIS Unequivocally Demonstrated By RNA Interference

Posted: September 5th, 2008, 12:00pm EDT

Black Women Less Likely Than White Women To Receive Follow-Up Treatments After Breast Cancer Surgery, Study Finds

Posted: September 5th, 2008, 11:00am EDT

Agendia Launches TargetPrint(R) For Breast Cancer Patients

Posted: September 5th, 2008, 7:00am EDT

Blacks Less Likely Than Whites To Receive Standard Of Care In Radiation Therapy For Breast Cancer

Posted: September 5th, 2008, 7:00am EDT

Change In HER2 Status After Treatment With Herceptin Discovered By M. D. Anderson Study

Posted: September 5th, 2008, 7:00am EDT